Avid Bioservices Inc (CDMO)

[entdoc]

4OurRetirement, the point is not whether China is using a slightly different Cotara. The point is there has been absolutely Zippo in the world literature about the Chinese experience with it after almost 10 years of being approved there for lung cancer. That was a part of the tech "give-away" to China deal, that the world would learn something because of it, and speed commercialization here. Instead, total silence. I wrote that I find it peculiar that nobody on this board or in the company has ever commented on this China phenomenon. If Cotara has efficacy in cancer treatment, other than if it is delivered through a special catheter threaded into the substance of a brain cancer, we should know it (unequivocably) by now. Comments anyone?